| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJCA.2017.09.035 |
| P698 | PubMed publication ID | 29096157 |
| P50 | author | David Cella | Q62568473 |
| Tomasz M Beer | Q90949746 | ||
| P2093 | author name string | Kurt Miller | |
| Bertrand Tombal | |||
| De Phung | |||
| Cristina Ivanescu | |||
| Konstantina Skaltsa | |||
| Shevani Naidoo | |||
| Stefan Holmstrom | |||
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 21-29 | |
| P577 | publication date | 2017-10-30 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies | |
| P478 | volume | 87 |
| Q90289244 | Cancer symptom response as an oncology clinical trial end point |
| Q90395596 | Enzalutamide: A Review in Castration-Resistant Prostate Cancer |
| Q90608233 | Gender Differences in Patient-Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease |
| Q57170878 | Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study |
| Q91632011 | Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial |
| Q91665125 | Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review |
| Q90294430 | Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews |
Search more.